The use of a clinical decision support tool to assess the risk of QT drug–drug interactions in community pharmacies

by Florine A. Berger, Heleen van der Sijs, Teun van Gelder, Patricia M. L. A. van den Bemt
Published 2021-02-01

Development and validation of a tool to assess the risk of QT drug-drug interactions in clinical practice

by Florine A. Berger, Heleen van der Sijs, Matthijs L. Becker, Teun van Gelder, Patricia M. L. A. van den Bemt
Published 2020-07-01

The Development of Practice Recommendations for Drug-Disease Interactions by Literature Review and Expert Opinion

by Justine M. Z. van Tongeren, S. Froukje Harkes-Idzinga, Heleen van der Sijs, Roya Atiqi, Bart J. F. van den Bemt, Bart J. F. van den Bemt, L. Willem Draijer, Deline Hiel, Adrian Kerremans, Bart Kremers, Marc de Leeuw, Marleen V. Olthoff, T. Kim-Loan Pham, Ricky Valentijn-Robertz, Kayan Tsoi, Iris Wichers, Maaike de Wit, Sander D. Borgsteede, Sander D. Borgsteede
Published 2020-05-01